News

MedPodium’s Nutra-Apps are small, pharmaceutically-sealed, tasteless, easy-use capsules in pocket-sized packaging, designed to promote personal health. The Neo-Energy product is a dietary supplement capsule without any sugar, calories,

The company claims that once developed and approved, ITCA 650 would be the first and only once-yearly injection-free GLP-1 therapy for the treatment of Type 2 diabetes that

Utilizing a novel technology called Particle Replication In Non-Wetting Templates (PRINT) platform, Liquidia is developing rationally designed carriers for improved delivery of small molecule and biological cargos. Liquidia

The initiative follows a formal pre-NDA verification with the FDA that verified the results from Tarsa’s Phase III ORACAL trial and the requirements for regulatory approval. The Phase

The funds will be used for the preclinical development of m102.4, an antibody indicated as a post-exposure prophylactic against Nipah or Hendra virus infection, that can lead to

Both the companies hope to make use of their resources to promote vital university clinical development. The agreement will make use of IntelliCell’s expertise in separation of adipose

The deal covers the production of MoxDuo Capsules, which will be supplied in the US market through 2015 and an immediate-release Dual Opioid pain therapy containing morphine and

The company has upgraded its existing operating system with centralized web-based application for its growing supply chain organization. Maestro is believed to have a flexible architecture which allows

INC424, an oral inhibitor of the JAK1 and JAK2 tyrosine kinases, is being evaluated in primary myelofibrosis as well as post-polycythemia vera myelofibrosis (PPV-MF), post-essential thrombocythemia myelofibrosis (PET-MF),